Knowledge of centers for disease control and prevention guidelines for the use of vancomycin at a large tertiary care children's hospital

Journal of Pediatrics

Volumn 137, Issue 5, 2000, Pages 694-700

  Lin, P Ling ^a   Oram, Ronda J ^a   Lauderdale, Diane S ^a   Dean, Roger ^a   Daum, Robert S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; COLITIS; DISEASE CONTROL; FEVER; HUMAN; INFECTION PREVENTION; MEDICAL EDUCATION; NEUTROPENIA; PEDIATRIC HOSPITAL; PEDIATRICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESIDENT; WOUND INFECTION;

EID: 0033740049     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.109113     Document Type: Article

References (35)

1. Historical yearly usage of vancomycin
2. Epidemiology, appropriateness, and cost of vancomycin use
3. Nosocomial outbreak clue to Enteracaccus faecium highly resistant to vancomycin, penicillin, and gentamicin
4. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993
5. Emergence of vancomycin resistance in coagulase-negative staphylococci
6. Reduced susceptibility of Staphylococcus aureus to vancomycin-Japan, 1996
7. Staphylococcus epidermidis: Emerging resistance and need for alternative agents
8. Vancomycin resistance in Staphylococcus, haemolyticus causing colonization and blood-stream infection
9. Health and economic impacts of antimicrobial resistance
10. Recommendations for preventing the spread of vancomycin resistance
11. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals
12. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycln-resistant enterococcus
13. Evaluation of vancomycin use in a pediatric teaching hospital based on CDC criteria
14. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium
15. Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention
16. Appropriateness of vancomycin use in the emergency department
17. Vancomycin use in a university medical center: Comparison with hospital infection control practices advisory committee guidelines
18. Vancomycin use in a university medical center: Comparison with hospital infection control practices advisory committee guidelines
19. Epidemiology of vancomycin usage at a children's hospital, 1993-1995
20. Vancomycin for Staphylacoccus aureus endocarditis in intravenous drug users
21. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylacoccus aureus endocarditis in rats and role of test conditions in this determination
22. A study of antimicrobial misuse in a university hospital
23. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations: A double-blind randomized trial
24. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients
25. Vancomycin control measures at a tertiary care hospital: Impact of interventions on volume and patterns of use
26. Grampositive infections and the use of vancomycin in 550 episodes of fever and neutropenia
27. Treatment of asymptomatic Clastridium difficile carriers (fecal excretors) with vancomycin or metronidazole
28. Diagnosis and treatment of Clostridium difficile colitis
29. Comparison of vancomycin, teicoplanin, metronidazole, and fusidlc acid for the treatment of Clostrtidium difficile-associated diarrhea
30. Recurrent Clastridium difficile diarrhea: Characteristics of and risk factor for patients enrolled in a prospective, randomized, double-blinded trial
31. A case successfully treated by conservative management for mediastinitis in infected composite graft clue to methicillin-resistant coagulase negative staphylococcus
32. Anterior chamber concentrations of vancomycin in the irrigating solution at the end of cataract surgery
33. Malis and prophylactic antibiotics
34. The epidemiology of intravenous vancomycin usage in a university hospital. A 10 year study
35. Pneumococcal infections